Nature Reviews Cardiology最新文献

筛选
英文 中文
Cardiovascular risk, evaluation and management in patients with hypertriglyceridaemia: a Consensus Statement from the International Atherosclerosis Society. 高甘油三酯血症患者的心血管风险、评估和管理:国际动脉粥样硬化学会的共识声明
IF 50.2 1区 医学
Nature Reviews Cardiology Pub Date : 2026-11-12 DOI: 10.1038/s41569-026-01358-9
Rahul Aggarwal, Christina Bursill, Gemma A Figtree, Samantha L Hocking, R Preston Mason, Erin D Michos, Michael Miller, Adam J Nelson, Stephen J Nicholls, Kerry-Anne Rye, Ph Gabriel Steg, Gerald F Watts, Sophia Zoungas, Peter Libby
{"title":"Cardiovascular risk, evaluation and management in patients with hypertriglyceridaemia: a Consensus Statement from the International Atherosclerosis Society.","authors":"Rahul Aggarwal, Christina Bursill, Gemma A Figtree, Samantha L Hocking, R Preston Mason, Erin D Michos, Michael Miller, Adam J Nelson, Stephen J Nicholls, Kerry-Anne Rye, Ph Gabriel Steg, Gerald F Watts, Sophia Zoungas, Peter Libby","doi":"10.1038/s41569-026-01358-9","DOIUrl":"https://doi.org/10.1038/s41569-026-01358-9","url":null,"abstract":"<p><p>The prevalence of hypertriglyceridaemia is increasing globally owing to high rates of obesity and diabetes mellitus. Hypertriglyceridaemia is associated with an increased risk of cardiovascular disease, mediated through the cholesterol content of triglyceride-rich lipoprotein remnant particles rather than through triglycerides per se. Although plasma levels of triglycerides can be measured with a simple blood test, hypertriglyceridaemia remains underdiagnosed and undertreated. Hypertriglyceridaemia can result from various primary or secondary aetiologies, the identification and management of which is an important first step. Hypertriglyceridaemia can be managed with lifestyle measures, lipid-lowering therapy with statins in indicated patients to reduce cholesterol levels and, in refractory situations, with the addition of triglyceride-specific pharmacological therapies. Emerging therapies with considerable promise for the management of hypertriglyceridaemia include those targeting apolipoprotein C-III, angiopoietin-related protein 3 or fibroblast growth factor 21. However, so far, there is no evidence from randomized clinical trials that pharmacotherapies targeting triglycerides can reduce the occurrence of cardiovascular events, suggesting that elevated levels of triglycerides serve as a marker of atherosclerotic risk that should prompt optimization of modifiable cardiovascular risk factors. In this Consensus Statement, we provide clinical context and evidence for the evaluation, diagnosis and management of hypertriglyceridaemia.</p>","PeriodicalId":18976,"journal":{"name":"Nature Reviews Cardiology","volume":" ","pages":""},"PeriodicalIF":50.2,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149408495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A selective vasodilator targeting pericytes reverses capillary no-reflow in ischaemia-reperfusion injury. 选择性血管扩张剂靶向周细胞逆转缺血再灌注损伤毛细血管无血流。
IF 50.2 1区 医学
Nature Reviews Cardiology Pub Date : 2026-11-09 DOI: 10.1038/s41569-026-01364-x
Irene Fernández-Ruiz
{"title":"A selective vasodilator targeting pericytes reverses capillary no-reflow in ischaemia-reperfusion injury.","authors":"Irene Fernández-Ruiz","doi":"10.1038/s41569-026-01364-x","DOIUrl":"https://doi.org/10.1038/s41569-026-01364-x","url":null,"abstract":"","PeriodicalId":18976,"journal":{"name":"Nature Reviews Cardiology","volume":" ","pages":""},"PeriodicalIF":50.2,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149379690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiac and vascular involvement in protein misfolding diseases. 心脏和血管参与蛋白质错误折叠疾病。
IF 50.2 1区 医学
Nature Reviews Cardiology Pub Date : 2026-11-05 DOI: 10.1038/s41569-026-01359-8
Kimon Stamatelopoulos, Georgios Georgiopoulos, Alberto Aimo, Evmorfia Aivalioti, Karen Carolyn Bauer, Simon Tual-Chalot, Simon Kraler, Dimitrios Bampatsias, Mario Nuvolone, Mahmoud Abdellatif, Dimitrios Delialis, Christoph Laske, Alexandros Briasoulis, Charalambos Vlachopoulos, Nektarios Tavernarakis, Michele Vendruscolo, Michele Emdin, Thorsten Hoppe, Ioannis Trougakos, Giovanni Palladini, Efstathios Kastritis, Mathew S Maurer, Marianna Fontana, Konstantinos Stellos
{"title":"Cardiac and vascular involvement in protein misfolding diseases.","authors":"Kimon Stamatelopoulos, Georgios Georgiopoulos, Alberto Aimo, Evmorfia Aivalioti, Karen Carolyn Bauer, Simon Tual-Chalot, Simon Kraler, Dimitrios Bampatsias, Mario Nuvolone, Mahmoud Abdellatif, Dimitrios Delialis, Christoph Laske, Alexandros Briasoulis, Charalambos Vlachopoulos, Nektarios Tavernarakis, Michele Vendruscolo, Michele Emdin, Thorsten Hoppe, Ioannis Trougakos, Giovanni Palladini, Efstathios Kastritis, Mathew S Maurer, Marianna Fontana, Konstantinos Stellos","doi":"10.1038/s41569-026-01359-8","DOIUrl":"https://doi.org/10.1038/s41569-026-01359-8","url":null,"abstract":"<p><p>Protein misfolding diseases impose a substantial and often under-recognized burden on both the heart and vasculature. In this Review, we outline how the failure of proteostasis drives oligomer toxicity, amyloid deposition and inflammation in cardiovascular tissues as well as microvascular injury and thrombosis, which culminate in cardiovascular dysfunction. We define the cardiovascular hallmarks of protein misfolding diseases, focusing on transthyretin amyloidosis and immunoglobulin light chain amyloidosis, and the disease-specific organ tropisms. We examine neurodegenerative proteinopathies affecting the heart-vascular-brain axis, highlighting how amyloid-β and α-synuclein accumulation contribute to dysautonomia, vascular dysfunction and adverse outcomes. We summarize diagnostic pathways and clinical indicators for early diagnosis of cardiovascular involvement in protein misfolding diseases and review established and emerging biomarkers of vascular stress and proteotoxic load. We also map the current therapeutic landscape for protein misfolding diseases, including strategies to reduce the synthesis of precursor proteins or promote the stabilization of mature proteins as well as fibril-directed therapies, and discuss remaining challenges, such as residual cardiovascular risk, that support the development of mechanism-informed therapeutic approaches. Finally, we propose a research roadmap that prioritizes systematic cardiovascular screening in at-risk populations, harmonized methods for vascular phenotyping, biomarker-anchored mechanistic clinical trials across protein misfolding diseases, and artificial intelligence-based approaches and precision medicine frameworks that integrate genotype or distinct protein conformational strain patterns, organ tropism and dynamic proteostasis measures.</p>","PeriodicalId":18976,"journal":{"name":"Nature Reviews Cardiology","volume":" ","pages":""},"PeriodicalIF":50.2,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149343002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiovascular resilience in centenarians. 百岁老人的心血管恢复能力。
IF 50.2 1区 医学
Nature Reviews Cardiology Pub Date : 2026-10-26 DOI: 10.1038/s41569-026-01348-x
Pedro Carrera-Bastos, Abel Plaza-Florido, Inmaculada Pérez-Prieto, Shlomit Radom-Aizik, Claudio Franceschi, Carlos Rodríguez-López, José Antonio Serra-Rexach, Enzo Emanuele, Alejandro Lucia
{"title":"Cardiovascular resilience in centenarians.","authors":"Pedro Carrera-Bastos, Abel Plaza-Florido, Inmaculada Pérez-Prieto, Shlomit Radom-Aizik, Claudio Franceschi, Carlos Rodríguez-López, José Antonio Serra-Rexach, Enzo Emanuele, Alejandro Lucia","doi":"10.1038/s41569-026-01348-x","DOIUrl":"https://doi.org/10.1038/s41569-026-01348-x","url":null,"abstract":"<p><p>Centenarians - individuals aged ≥100 years - provide a unique human model for understanding resilience to cardiovascular ageing. Although cardiovascular and metabolic diseases, including hypertension, heart failure, atrial fibrillation and chronic kidney disease, are common in centenarians, their onset is typically delayed relative to that in individuals aged 80-100 years. Centenarians characteristically have structural changes in the heart and vessels, including concentric left ventricular remodelling, increased myocardial stiffness and vascular ageing, but often without the expected burden of myocardial infarction or overt heart failure. Their cardiometabolic profile is generally favourable, marked by preserved insulin sensitivity in cohorts with a low prevalence of diabetes mellitus, mid-range lipid levels and a low prevalence of obesity. Centenarians also have a distinctive inflammatory and gastrointestinal phenotype, characterized by chronic low-grade inflammation with elevated anti-inflammatory signalling, a gut microbiome that more closely resembles that of younger adults, and preserved intestinal barrier integrity. Genetically and epigenetically, exceptional longevity reflects highly polygenic contributions, selective maintenance of genomic stability and markedly younger epigenetic age compared with chronological age. In this Review, we summarize data on the cardiovascular system among centenarians by framing observations of longevity as a composite of delayed pathology, adaptive compensation and survivorship selection. Understanding the biological, behavioural and environmental mechanisms underlying cardiovascular resilience in extreme longevity might inform strategies to extend cardiovascular healthspan across all ages.</p>","PeriodicalId":18976,"journal":{"name":"Nature Reviews Cardiology","volume":" ","pages":""},"PeriodicalIF":50.2,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149270769","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The evolution and future of conduction system pacing. 传导系统起搏的发展与未来。
IF 50.2 1区 医学
Nature Reviews Cardiology Pub Date : 2026-10-23 DOI: 10.1038/s41569-026-01354-z
So-Ryoung Lee, Pugazhendhi Vijayaraman, Weijian Huang, Marek Jastrzębski, Jacqueline Joza, Haran Burri, Shunmuga Sundaram Ponnusamy, Roderick Tung, Daniel Lustgarten, Eue-Keun Choi
{"title":"The evolution and future of conduction system pacing.","authors":"So-Ryoung Lee, Pugazhendhi Vijayaraman, Weijian Huang, Marek Jastrzębski, Jacqueline Joza, Haran Burri, Shunmuga Sundaram Ponnusamy, Roderick Tung, Daniel Lustgarten, Eue-Keun Choi","doi":"10.1038/s41569-026-01354-z","DOIUrl":"https://doi.org/10.1038/s41569-026-01354-z","url":null,"abstract":"<p><p>Cardiac pacing has undergone a fundamental paradigm shift from conventional right ventricular apical pacing towards physiological activation of the native conduction system of the heart. Decades of evidence have established that chronic right ventricular pacing induces ventricular dyssynchrony, contributing to pacing-induced cardiomyopathy and adverse clinical outcomes. Conduction system pacing, which engages the intrinsic His-Purkinje network of the heart, has emerged as a transformative approach that preserves or restores the natural ventricular activation sequence. His bundle pacing, the earliest form of conduction system pacing, provided proof of concept but is limited by technical challenges and high capture thresholds. Left bundle branch area pacing has since become the dominant modality, offering greater procedural success, lead stability and broader applicability: from management of bradycardia and prevention of pacing-induced cardiomyopathy to cardiac resynchronization therapy in heart failure. Bachmann bundle area pacing is an emerging atrial counterpart: by capturing a preferential interatrial conduction pathway, this approach reduces interatrial conduction delay and produces a more physiological atrial activation sequence than conventional right atrial appendage pacing. Bachmann bundle area pacing might, therefore, help to prevent atrial fibrillation. In this Review, we bring these ventricular and atrial strategies together under the unifying principle of physiological pacing, describe their mechanistic basis and technical evolution, appraise the latest evidence from randomized trials and address the practical questions that arise in clinical application, indicating where more evidence is required.</p>","PeriodicalId":18976,"journal":{"name":"Nature Reviews Cardiology","volume":" ","pages":""},"PeriodicalIF":50.2,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149245597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Distinguishing between nicotine replacement therapies and nicotine-containing consumer products. 区分尼古丁替代疗法和含尼古丁的消费产品。
IF 50.2 1区 医学
Nature Reviews Cardiology Pub Date : 2026-10-22 DOI: 10.1038/s41569-026-01362-z
Ivan Berlin, Daniel Thomas
{"title":"Distinguishing between nicotine replacement therapies and nicotine-containing consumer products.","authors":"Ivan Berlin, Daniel Thomas","doi":"10.1038/s41569-026-01362-z","DOIUrl":"https://doi.org/10.1038/s41569-026-01362-z","url":null,"abstract":"","PeriodicalId":18976,"journal":{"name":"Nature Reviews Cardiology","volume":" ","pages":""},"PeriodicalIF":50.2,"publicationDate":"2026-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149245576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to 'Distinguishing between nicotine replacement therapies and nicotine-containing consumer products'. 回复“区分尼古丁替代疗法和含尼古丁消费品”。
IF 50.2 1区 医学
Nature Reviews Cardiology Pub Date : 2026-10-22 DOI: 10.1038/s41569-026-01361-0
Thomas Münzel, Marin Kuntic, John F Keaney, Julia Lurz, Filippo Crea, Thomas F Lüscher, Sanjay Rajagopalan, Andreas Daiber
{"title":"Reply to 'Distinguishing between nicotine replacement therapies and nicotine-containing consumer products'.","authors":"Thomas Münzel, Marin Kuntic, John F Keaney, Julia Lurz, Filippo Crea, Thomas F Lüscher, Sanjay Rajagopalan, Andreas Daiber","doi":"10.1038/s41569-026-01361-0","DOIUrl":"https://doi.org/10.1038/s41569-026-01361-0","url":null,"abstract":"","PeriodicalId":18976,"journal":{"name":"Nature Reviews Cardiology","volume":" ","pages":""},"PeriodicalIF":50.2,"publicationDate":"2026-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149245558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Duration of antibiotic treatment for infective endocarditis: should we move towards tailored therapy? 抗生素治疗感染性心内膜炎的持续时间:我们是否应该转向量身定制的治疗?
IF 50.2 1区 医学
Nature Reviews Cardiology Pub Date : 2026-10-15 DOI: 10.1038/s41569-026-01360-1
Mary Philip, Gilbert Habib
{"title":"Duration of antibiotic treatment for infective endocarditis: should we move towards tailored therapy?","authors":"Mary Philip, Gilbert Habib","doi":"10.1038/s41569-026-01360-1","DOIUrl":"https://doi.org/10.1038/s41569-026-01360-1","url":null,"abstract":"","PeriodicalId":18976,"journal":{"name":"Nature Reviews Cardiology","volume":" ","pages":""},"PeriodicalIF":50.2,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149194653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heart-specific T cell responses: from antigens to disease mechanisms. 心脏特异性T细胞反应:从抗原到疾病机制。
IF 50.2 1区 医学
Nature Reviews Cardiology Pub Date : 2026-10-12 DOI: 10.1038/s41569-026-01356-x
Gustavo Campos Ramos
{"title":"Heart-specific T cell responses: from antigens to disease mechanisms.","authors":"Gustavo Campos Ramos","doi":"10.1038/s41569-026-01356-x","DOIUrl":"https://doi.org/10.1038/s41569-026-01356-x","url":null,"abstract":"<p><p>The field of immunology has transformed our understanding of myocardial cell biology and paved the way for new pathophysiological concepts in cardiology. Researchers have sought to elucidate the contributions of nonspecific inflammatory mechanisms to cardiac diseases, and an increasing number of clinical trials have explored anti-inflammatory approaches in cardiovascular disease. Moreover, adaptive immune mechanisms directed to cardiac proteins released by dying cardiomyocytes have been reported across a broad spectrum of conditions, including acute myocarditis, myocardial infarction and heart failure, and have gained increasing attention. This concept of antigen-specific cardio-immune crosstalk could pave the way for a deeper understanding of tissue-specific disease mechanisms and facilitate the development of targeted interventions. However, only a small number of cardiac antigens have been identified so far, and an immunological definition of heart specificity remains elusive. This Review revisits the molecular composition of the heart from the perspective of T cells to describe the most relevant cardiac antigens identified to date, thus defining a framework for identifying novel T cell reactivities in the injured heart. Going forward, these insights might pave the way for the development of new tools to track specific T cells across various cardiac diseases, in contexts ranging from model organisms to patients.</p>","PeriodicalId":18976,"journal":{"name":"Nature Reviews Cardiology","volume":" ","pages":""},"PeriodicalIF":50.2,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149170176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond glucose lowering and ketogenesis: unveiling new cardioprotective mechanisms of SGLT2 inhibitors 超越降糖和生酮:揭示SGLT2抑制剂的新的心脏保护机制
IF 49.6 1区 医学
Nature Reviews Cardiology Pub Date : 2026-10-02 DOI: 10.1038/s41569-026-01357-w
Alessia Riccio,Gaetano Santulli
{"title":"Beyond glucose lowering and ketogenesis: unveiling new cardioprotective mechanisms of SGLT2 inhibitors","authors":"Alessia Riccio,Gaetano Santulli","doi":"10.1038/s41569-026-01357-w","DOIUrl":"https://doi.org/10.1038/s41569-026-01357-w","url":null,"abstract":"","PeriodicalId":18976,"journal":{"name":"Nature Reviews Cardiology","volume":"36 1","pages":""},"PeriodicalIF":49.6,"publicationDate":"2026-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149087951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书